Paired-like homeobox gene (PHOX2B) nonpolyalanine repeat expansion mutations (NPARMs): genotype-phenotype correlation in congenital central hypoventilation syndrome (CCHS).


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
09 2021
Historique:
received: 01 10 2020
accepted: 02 04 2021
revised: 02 04 2021
pubmed: 8 5 2021
medline: 21 10 2021
entrez: 7 5 2021
Statut: ppublish

Résumé

CCHS is an extremely rare congenital disorder requiring artificial ventilation as life support. Typically caused by heterozygous polyalanine repeat expansion mutations (PARMs) in the PHOX2B gene, identification of a relationship between PARM length and phenotype severity has enabled anticipatory management. However, for patients with non-PARMs in PHOX2B (NPARMs, ~10% of CCHS patients), a genotype-phenotype correlation has not been established. This comprehensive report of PHOX2B NPARMs and associated phenotypes, aims at elucidating potential genotype-phenotype correlations that will guide anticipatory management. An international collaboration (clinical, commercial, and research laboratories) was established to collect/share information on novel and previously published PHOX2B NPARM cases. Variants were categorized by type and gene location. Categorical data were analyzed with chi-square and Fisher's exact test; further pairwise comparisons were made on significant results. Three hundred two individuals with PHOX2B NPARMs were identified, including 139 previously unreported cases. Findings demonstrate significant associations between key phenotypic manifestations of CCHS and variant type, location, and predicted effect on protein function. This study presents the largest cohort of PHOX2B NPARMs and associated phenotype data to date, enabling genotype-phenotype studies that will advance personalized, anticipatory management and help elucidate pathological mechanisms. Further characterization of PHOX2B NPARMs demands longitudinal clinical follow-up through international registries.

Identifiants

pubmed: 33958749
doi: 10.1038/s41436-021-01178-x
pii: S1098-3600(21)05088-7
doi:

Substances chimiques

Homeodomain Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1656-1663

Informations de copyright

© 2021. The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics.

Références

Mellins, R. B., Balfour, H. H. Jr., Turino, G. M. & Winters, R. W. Failure of automatic control of ventilation (Ondine’s curse). Report of an infant born with this syndrome and review of the literature. Medicine (Baltimore). 49, 487–504 (1970).
doi: 10.1097/00005792-197011000-00003
Weese-Mayer, D. E. et al. An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am. J. Respir. Crit. Care Med. 181, 626–644 (2010).
doi: 10.1164/rccm.200807-1069ST
Amiel, J. et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat. Genet. 33, 459–461 (2003).
doi: 10.1038/ng1130
Weese-Mayer, D. E. et al. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am. J. Med. Genet. A. 123A, 267–278 (2003).
doi: 10.1002/ajmg.a.20527
Pattyn, A., Morin, X., Cremer, H., Goridis, C. & Brunet, J. F. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development. 124, 4065–4075 (1997).
doi: 10.1242/dev.124.20.4065
Pattyn, A., Morin, X., Cremer, H., Goridis, C. & Brunet, J. F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature. 399, 366–370 (1999).
doi: 10.1038/20700
Howard, M. J. Mechanisms and perspectives on differentiation of autonomic neurons. Dev. Biol. 277, 271–286 (2005).
doi: 10.1016/j.ydbio.2004.09.034
Weese-Mayer, D. E. et al. Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndrome. Am. J. Med. Genet. 100, 237–245 (2001).
doi: 10.1002/ajmg.1249
Marazita, M. L. et al. Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with idiopathic congenital central hypoventilation syndrome. Am. J. Med. Genet. 100, 229–236 (2001).
doi: 10.1002/ajmg.1284
Matera, I. et al. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset central hypoventilation syndrome. J. Med. Genet. 41, 373–380 (2004).
doi: 10.1136/jmg.2003.015412
Trochet, D. et al. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am. J. Hum. Genet. 76, 421–426 (2005).
doi: 10.1086/428366
Berry-Kravis, E. M., Zhou, L., Rand, C. M. & Weese-Mayer, D. E. Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am. J. Respir. Crit. Care Med. 174, 1139–1144 (2006).
doi: 10.1164/rccm.200602-305OC
Nagashimada, M. et al. Autonomic neurocristopathy-associated mutations in PHOX2B dysregulate Sox10 expression. J. Clin. Invest. 122, 3145–3158 (2012).
doi: 10.1172/JCI63401
Di Lascio, S., Bachetti, T., Saba, E., Ceccherini, I., Benfante, R. & Fornasari, D. Transcriptional dysregulation and impairment of PHOX2B auto-regulatory mechanism induced by polyalanine expansion mutations associated with congenital central hypoventilation syndrome. Neurobiol. Dis. 50, 187–200 (2013).
doi: 10.1016/j.nbd.2012.10.019
Di Lascio, S., Belperio, D., Benfante, R. & Fornasari, D. Alanine expansions associated with congenital central hypoventilation syndrome impair PHOX2B homeodomain-mediated dimerization and nuclear import. J. Biol. Chem. 291, 13375–13393 (2016).
doi: 10.1074/jbc.M115.679027
Di Lascio, S. et al. Structural and functional differences in PHOX2B frameshift mutations underlie isolated or syndromic congenital central hypoventilation syndrome. Hum. Mutat. 39, 219–236 (2018).
doi: 10.1002/humu.23365
Pei, D., Luther, W., Wang, W., Paw, B. H., Stewart, R. A. & George, R. E. Distinct neuroblastoma-associated alterations of PHOX2B impair sympathetic neuronal differentiation in zebrafish models. PLoS Genet. 9, e1003533 (2013).
doi: 10.1371/journal.pgen.1003533
Lindeboom, R. G. H., Vermeulen, M., Lehner, B. & Supek, F. The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy. Nat. Genet. 51, 1645–1651 (2019).
doi: 10.1038/s41588-019-0517-5
Jennings, L. J., Yu, M., Zhou, L., Rand, C. M., Berry-Kravis, E. M. & Weese-Mayer, D. E. Comparison of PHOX2B testing methods in the diagnosis of congenital central hypoventilation syndrome and mosaic carriers. Diagn. Mol. Pathol. 19, 224–231 (2010).
doi: 10.1097/PDM.0b013e3181eb92ff
Horiuchi, H. et al. Sensitive detection of polyalanine expansions in PHOX2B by polymerase chain reaction using bisulfite-converted DNA. J. Mol. Diagn. 7, 638–640 (2005).
doi: 10.1016/S1525-1578(10)60598-3
den Dunnen, J. T. et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum. Mutat. 37, 564–569 (2016).
doi: 10.1002/humu.22981
Ou-Yang, M. C. et al. Concomitant existence of total bowel aganglionosis and congenital central hypoventilation syndrome in a neonate with PHOX2B gene mutation. J. Pediatr. Surg. 42, e9–e11 (2007).
doi: 10.1016/j.jpedsurg.2006.10.022
Bachetti, T. & Ceccherini, I. PHOX2B (paired‐like homeobox 2b). Atlas Genet. Cytogenet. Oncol. Haematol. 17, 740–745 (2013).
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 581, 434–443 (2020).
doi: 10.1038/s41586-020-2308-7
Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062–D1067 (2018).
doi: 10.1093/nar/gkx1153
Raabe, E. H. et al. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene. 27, 469–476 (2008).
doi: 10.1038/sj.onc.1210659
Jennings, L. J. et al. Variable human phenotype associated with novel deletions of the PHOX2B gene. Pediatr. Pulmonol. 47, 153–161 (2012).
doi: 10.1002/ppul.21527
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
doi: 10.1038/gim.2015.30
Bachetti, T. & Ceccherini, I. Causative and common PHOX2B variants define a broad phenotypic spectrum. Clin. Genet. 97, 103–113 (2020).
doi: 10.1111/cge.13633
Lindeboom, R. G., Supek, F. & Lehner, B. The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat. Genet. 48, 1112–1118 (2016).
doi: 10.1038/ng.3664
Bygarski, E., Paterson, M. & Lemire, E. G. Extreme intra-familial variability of congenital central hypoventilation syndrome: a case series. J. Med. Case Rep. 7, 117 (2013).
doi: 10.1186/1752-1947-7-117
Cain, J. T. et al. Nonsense pathogenic variants in exon 1 of PHOX2B lead to translational reinitiation in congenital central hypoventilation syndrome. Am. J. Med. Genet. A. 173, 1200–1207 (2017).
doi: 10.1002/ajmg.a.38162
Sasaki, A. et al. Novel PHOX2B mutations in congenital central hypoventilation syndrome. Pediatr. Int. 61, 393–396 (2019).
doi: 10.1111/ped.13812
Low, K. J. et al. A case of congenital central hypoventilation syndrome in a three-generation family with non-polyalanine repeat PHOX2B mutation. Pediatr. Pulmonol. 49, E140–E143 (2014).
doi: 10.1002/ppul.23051
Byers, H. M., Chen, M., Gelfand, A. S., Ong, B., Jendras, M. & Glass, I. A. Expanding the phenotype of congenital central hypoventilation syndrome impacts management decisions. Am. J. Med. Genet. A. 176, 1398–1404 (2018).
doi: 10.1002/ajmg.a.38726
Katwa, U. et al. Atypical presentations associated with non-polyalanine repeat PHOX2B mutations. Am. J. Med. Genet. A. 176, 1627–1631 (2018).
doi: 10.1002/ajmg.a.38720

Auteurs

Amy Zhou (A)

Department of Pediatrics, Division of Autonomic Medicine, Center for Autonomic Medicine in Pediatrics (CAMP), Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, IL, USA.

Casey M Rand (CM)

Department of Pediatrics, Division of Autonomic Medicine, Center for Autonomic Medicine in Pediatrics (CAMP), Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, IL, USA.

Sara M Hockney (SM)

Department of Pediatrics, Division of Autonomic Medicine, Center for Autonomic Medicine in Pediatrics (CAMP), Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, IL, USA.
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Grace Niewijk (G)

Department of Pediatrics, Division of Autonomic Medicine, Center for Autonomic Medicine in Pediatrics (CAMP), Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, IL, USA.

Patrick Reineke (P)

Ambry Genetics, Aliso Viejo, CA, USA.

Virginia Speare (V)

Ambry Genetics, Aliso Viejo, CA, USA.

Elizabeth M Berry-Kravis (EM)

Departments of Pediatrics, Neurology, and Biochemistry, Molecular Diagnostics Laboratory, Rush University Medical Center, Chicago, IL, USA.

Lili Zhou (L)

Departments of Pediatrics, Neurology, and Biochemistry, Molecular Diagnostics Laboratory, Rush University Medical Center, Chicago, IL, USA.

Lawrence J Jennings (LJ)

Department of Pathology, Molecular Diagnostics Laboratory, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Min Yu (M)

Department of Pathology, Molecular Diagnostics Laboratory, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Isabella Ceccherini (I)

IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Tiziana Bachetti (T)

IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Lab Neurobiologia dello Sviluppo, Dip. Scienze della Terra dell'Ambiente e della Vita (DISTAV), Università di Genova, Genova, Italy.

Melanie Pennock (M)

North Bristol NHS Trust, Bristol, UK.

Kai Lee Yap (KL)

Department of Pathology, Molecular Diagnostics Laboratory, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Debra E Weese-Mayer (DE)

Department of Pediatrics, Division of Autonomic Medicine, Center for Autonomic Medicine in Pediatrics (CAMP), Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, IL, USA. D-Weese-Mayer@Northwestern.edu.
Northwestern University Feinberg School of Medicine, Chicago, IL, USA. D-Weese-Mayer@Northwestern.edu.
Department of Pediatrics, Pediatric Autonomic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. D-Weese-Mayer@Northwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH